Close
24/07/2014
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers from the Universitat Politècnica de Catalunya - BarcelonaTech (UPC), the Institute of Medical Chemistry (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria. They have analysed the crystalline structure of the DNA with the drug by performing X-ray diffraction experiments at the ALBA Synchrotron. This work has been published in the journal Acta Crystallographica D.

Read the full press release published by the ALBA Synchrotron

More news

14/12/2018 The Open Innovation Forum matches business challenges to academic solutions 07/12/2018 2017 BioCat report: The best of the Bioregion of Catalonia 30/11/2018 Barcelona Synchrotron Park’s Commitment to Sustainable Growth 23/11/2018 Astronomers led by IEEC reveal a cold super-Earth around Barnard’s star 16/11/2018 CRAG’s Researchers discover how to generate plants with enhanced drought resistance 08/11/2018 The Barcelona manifesto: for a city-led science and technology diplomacy
6 7 8 9 10 11 12 13 14 15 16